相关实验视频
Updated: Jun 13, 2025
10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.5K
PSD-95蛋白:在慢性疼痛中是一个有前途的治疗点
Lulin Ma1,2, Dongdong Sun3, Song Wen4,5
1Department of Pain Medicine, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, China.
Molecular neurobiology
|September 16, 2024
概括
后突触密度 (PSD) -95蛋白在慢性疼痛的发展中至关重要. 抑制PSD-95和相关蛋白质为有效管理慢性疼痛提供了一个有希望的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 慢性疼痛显著影响患者的生活质量,并构成了重大公共卫生挑战.
- 目前的治疗方法,如阿片类药物和NSAID,由于副作用而存在局限性,需要新的治疗点.
- 后突触密度 (PSD) -95蛋白与慢性疼痛的发展和持续有关.
研究的目的:
- 探索后突触密度 (PSD) -95蛋白在慢性疼痛中的作用.
- 确定PSD-95和相关蛋白质作为慢性疼痛的潜在治疗点.
- 审查针对PSD-95治疗疼痛的药物的现有证据.
主要方法:
- 在慢性疼痛模型中研究突触后密度 (PSD) -95蛋白的研究文献综述.
- 对PSD-95与参与疼痛信号传递的其他关键蛋白质相互作用的研究分析.
- 检查针对PSD-95.5的药物的临床前和临床数据.
主要成果:
- 过度表达后突触密度 (PSD) -95蛋白与慢性疼痛密切相关.
- PSD-95与关键蛋白质相互作用,包括NMDA受体 (NMDAR) 亚单元2B (GluN2B),AMPA受体 (AMPAR),卡尔莫杜林依赖蛋白激酶II (CaMKII),5-西二胺2A受体 (5-HT2AR) 和神经元氧化合成酶 (nNOS).
- 旨在抑制PSD-95表达及其相互作用的药物在治疗慢性疼痛方面表现出显著的疗效.
结论:
- 后突触密度 (PSD) -95蛋白质是慢性疼痛病理生理学的关键参与者.
- 针对PSD-95及其相互作用蛋白质是开发新的,有效的慢性疼痛疗法的有希望的策略.
- 需要进一步的研究,以充分阐明针对PSD-95途径的治疗潜力.
相关概念视频
01:25Analgesia and Pain Management
552
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
01:44Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K